Congenital penile curvature as a possible risk factor for the onset of Peyronie's disease, and psychological consequences of penile curvature
https://doi.org/10.4081/aiua.2023.11238
Accepted: February 17, 2023
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
Objective: To investigate a possible relationship between a history of congenital penile curvature (CPC) and Peyronie's disease (PD), and to characterize the psychological profile of patients suffering from PD, with or without concomitant CPC.
Methods: We included 519 patients with Peyronie's disease (PD), of which 73 were found to have underlaying CPC. As a comparator population, we selected 2166 patients without PD, referring to our tertiary care clinic. In this population we detected 15 subjects with CPC. All patients completed the GAD-7 (Generalized-Anxiety-Disorder - 7 questions) and the PHQ-9 (Patient-Health-Questionnaire - 9 questions) questionnaires.
Results: The overall prevalence of CPC in PD-patients was 14.07%, compared to a prevalence of 0.69% in the non-PD control population (p < 0.00001). Moderate-to-severe anxiety was found to be present in 89.4% of all PD-patients.
Significantly higher proportions of patients with CPC associated with PD showed severe anxiety, compared to patients with PD alone (57.5% vs. 36.7%, respectively, p = 0.0008). Moderate- severe depression was found to be present in 57.8% of all PD- patients. Significantly higher proportions of PD patients with a history of CPC showed severe depression, compared to patients with PD alone (13.6% vs. 3.36%, respectively, p < 0.0002). GAD-7 median scores were significantly higher in patients with more severe penile curvatures (> 45°; p = 0.029). We did not detect a statistically significant difference between PHQ-9 medi- an scores based on the severity of PD (p = 0.53). Analysis of PHQ-9 and GAD-7 median scores showed significantly worse depressive and anxious symptoms in younger patients
(p < 0.001 and p = 0.0013, respectively).
Conclusions: The presence of congenital-penile-curvature may represent a risk factor for the subsequent onset of Peyronie's disease. Moderate/severe anxiety and moderate/severe depression were reported in a high fraction of cases. Anxiety was significantly higher in patients with more severe penile-curvatures, and depression was present independently of the degree of penile curvature. Depression and anxiety were found to be more severe in younger subjects.
Hatzimouratidis K, Eardley I, Giuliano F, et al. EAU guidelines on penile curvature. Eur.Urol. 2012; 62:543-552. DOI: https://doi.org/10.1016/j.eururo.2012.05.040
Zachalski W, Krajka K, Matuszewski M. Evaluation of the treatment of congenital penile curvature including psychosexual assessment. J Sex Med. 2015; 12:1828-1835. DOI: https://doi.org/10.1111/jsm.12933
Catuogno C, Lanza T, Ventrice GA, et al. Medical therapy of con- genital curving of the penis without hypospadias. Int J Impotence Res. 1994; 6 (Suppl 1):D225.
Zachalski W, Matuszewski M, Krajka K, et al. Familial appearance of congenital penile curvature–case history of two brothers. Cent European J Urol. 2013; 66:217.
Darewicz B, Kudelski J, Szynaka B, et al. Ultrastructure of the tuni- ca albuginea in congenital penile curvature. J Urol. 2001; 166:1766- 1768. DOI: https://doi.org/10.1016/S0022-5347(05)65671-6
Ebbehøj J, Metz P. Congenital penile angulation. Br J Urol. 1987; 60:264-266. DOI: https://doi.org/10.1111/j.1464-410X.1987.tb05497.x
Lee SS, Meng E, Chuang FP, et al. Congenital penile curvature: long- term results of operative treatment using the plication procedure. Asian J Androl. 2004; 6:273-276.
Yachia D, Beyar M, Aridogan IA, et al. The incidence of congenital penile curvature. J Urol. 1993; 150:1478-1479. DOI: https://doi.org/10.1016/S0022-5347(17)35816-0
KelaÃmi, A. Congenital Penile Deviation and its Treatment with the NesbitAKelåmi Technique. Br J Urol. 1987; 60:261-263. DOI: https://doi.org/10.1111/j.1464-410X.1987.tb05496.x
Makovey I, Higuchi TT, Montague DK, et al. Congenital penile cur- vature: update and management. Curr Urol Rep. 2012; 13:290-297. DOI: https://doi.org/10.1007/s11934-012-0257-x
Donnahoo KK, Cain MP, Pope JC, Casale, et al. Etiology, manage- ment and surgical complications of congenital chordee without hypospa- dias. J Urol. 1998; 160:1120-1122. DOI: https://doi.org/10.1097/00005392-199809020-00041
Nesbit RM. Congenital curvature of the phallus: report of three cases with description of corrective operation. J Urol. 1965; 93:230- 232. DOI: https://doi.org/10.1016/S0022-5347(17)63751-0
Yachia, D. Modified corporoplasty for the treatment of penile cur- vature. J Urol. 1990; 143:80-82. DOI: https://doi.org/10.1016/S0022-5347(17)39871-3
Alei G, Danti M. The surgical treatment of penile curvature: a mod- ified Nesbit procedure. Int J Impot Res. 1990; 2(Suppl 2):431-432.
Giammusso B, Burrello M, Branchina A, et al. Modified corporo- plasty for ventral penile curvature: description of the technique and ini- tial results. J Urol. 2004; 171:1209-1211. DOI: https://doi.org/10.1097/01.ju.0000110297.98725.25
Mingin G, Baskin LS. Management of chordee in children and young adults. Urol Clin. 2002; 29:277-284. DOI: https://doi.org/10.1016/S0094-0143(02)00044-7
Sokolakis I. Hatzichristodoulou G. Current trends in the surgical treatment of congenital penile curvature. Int J Impot Res. 2020; 32:64- 74. DOI: https://doi.org/10.1038/s41443-019-0177-0
Bias WB, Nyberg Jr LM, Hochberg MC, et al. Peyronie's disease: a newly recognized autosomal-dominant trait. Am J Med Genet. 1982; 12:227-235. DOI: https://doi.org/10.1002/ajmg.1320120213
Devine CJJ, Somers KD, Jordan GH, et al. Proposal: trauma as the cause of the Peyronie's lesion. J Urol. 1997; 157:285-290. DOI: https://doi.org/10.1016/S0022-5347(01)65361-8
Pryor JP, Ralph DJ. Clinical presentations of Peyronie's disease. Int J Impot Res. 2002; 14:414-417. DOI: https://doi.org/10.1038/sj.ijir.3900877
Weidner W, Schroeder-Printzen I, Weiske WH, et al. Sexual dys- function in Peyronie's disease: an analysis of 222 patients without pre- vious local plaque therapy. J Urol. 1997; 157:325-328. DOI: https://doi.org/10.1016/S0022-5347(01)65370-9
Nelson CJ, Diblasio C, Kendirci M, et al. The chronology of depres- sion and distress in men with Peyronie's disease. J Sex Med. 2008; 5:1985-1990. DOI: https://doi.org/10.1111/j.1743-6109.2008.00895.x
Schwarzer U, Sommer F, Klotz T, et al. The prevalence of Peyronie's disease: results of a large survey. BJU Int. 2001; 88:727-730. DOI: https://doi.org/10.1046/j.1464-4096.2001.02436.x
Dibenedetti DB, Nguyen D, Zografos L, et al. A Population-Based Study of Peyronie's Disease: Prevalence and Treatment Patterns in the United States. Adv Urol. 2011;2011:282503. DOI: https://doi.org/10.1155/2011/282503
Stuntz M, Perlaky A, des Vignes F, et al. The prevalence of Peyronie's disease in the United States: a population-based study. PloS one. 2016; 11:e0150157. DOI: https://doi.org/10.1371/journal.pone.0150157
Levine LA, Larsen S. Diagnosis and management of Peyronie dis- ease. In: Wein AJ, Kavoussi LR, Partin AW, Peters CA, editors. Campbell-Walsh Urology, 11th ed. Philadelphia: Elsevier Saunders, 2015; 722–748.
Yousif A, Natale C, Hellstrom WJ. Conservative Therapy for Peyronie’s Disease: a Contemporary Review of the Literature. Curr Urol Rep. 2021; 22:1-12. DOI: https://doi.org/10.1007/s11934-020-01024-8
Natale C, McLellan DM, Yousif A. et al. Review of intralesional col- lagenase clostridium histolyticum injection therapy and related combi- nation therapies in the treatment of Peyronie's disease (an update). Sex Med Rev. 2021; 9:340-349. DOI: https://doi.org/10.1016/j.sxmr.2020.01.005
Chung E, Ralph D, Kagioglu A, et al. Evidence-based management guidelines on Peyronie's disease. J Sex Med. 2016; 13:905-923. DOI: https://doi.org/10.1016/j.jsxm.2016.04.062
Nehra A, Alterowitz R, Culkin DJ, et al. Peyronie’s disease: AUA guideline. J Urol. 2015; 194:745-753. DOI: https://doi.org/10.1016/j.juro.2015.05.098
Osmonov D, Ragheb A, Ward S, et al. ESSM Position Statement on Surgical Treatment of Peyronie's Disease. Sex Med. 2022; 10:100459. DOI: https://doi.org/10.1016/j.esxm.2021.100459
Tal R, Nabulsi O, Nelson CJ, et al. The psychosocial impact of penile reconstructive surgery for congenital penile deviation. J Sex Med. 2010; 7:121-128. DOI: https://doi.org/10.1111/j.1743-6109.2009.01574.x
Mayer M, Rey-Valzacchi G, Silva-Garretón A, et al. Patient satis- faction with correction of congenital penile curvature. Actas Urols Esp (Engl Ed). 2018; 42:414-419. DOI: https://doi.org/10.1016/j.acuroe.2018.05.003
Nelson CJ, Mulhall JP. Psychological impact of Peyronie's disease: a review. J Sex Med. 2013; 10:653-660. DOI: https://doi.org/10.1111/j.1743-6109.2012.02999.x
Terrier JE, Nelson CJ. Psychological aspects of Peyronie's disease. Transl Androl Urol. 2016; 5:290-295. DOI: https://doi.org/10.21037/tau.2016.05.14
Rompel R, Mueller-Eckhardt G, Schroeder-Printzen I, et al. HLA antigens in Peyronie's disease. Urol Int. 1994; 52:34-37. DOI: https://doi.org/10.1159/000282566
Herati AS, Pastuszak AW. The Genetic Basis of Peyronie's Disease: A Review. Sex Med Rev. 2016; 4:85-94. DOI: https://doi.org/10.1016/j.sxmr.2015.10.002
Dolmans GH, Werker PM, de Jong IJ, et al. LifeLines Cohort Study. WNT2 locus is involved in genetic susceptibility of Peyronie’s disease. J Sex Med. 2012; 9:1430–1434. DOI: https://doi.org/10.1111/j.1743-6109.2012.02704.x
Paulis G, De Giorgio G, Paulis L. Role of Oxidative Stress in Peyronie's Disease: Biochemical Evidence and Experiences of Treatment with Antioxidants. Int J Mol Sci. 2022; 15;23:15969. DOI: https://doi.org/10.3390/ijms232415969
World Medical Association. World Medical Association Declaration of Helsinki: ethical principles for medical research involving human sub- jects. JAMA. 2013;310:2191-4 DOI: https://doi.org/10.1001/jama.2013.281053
Spitzer RL, Kroenke K, Williams JB, Löwe B. A brief measure for assessing generalized anxiety disorder: the GAD-7. Arch Intern Med. 2006; 166:1092-1097. DOI: https://doi.org/10.1001/archinte.166.10.1092
Kroenke K, Spitzer RL, Williams JB. The PHQ-9: validity of a brief depression severity measure. J Gen Intern Med. 2001; 16:606-613. DOI: https://doi.org/10.1046/j.1525-1497.2001.016009606.x
Faul, F, Erdfelder, E, Lang, AG, and Buchner A: G*Power 3: A flex- ible statistical power analysis program for the social, behavioral, and biomedical sciences. Behav Res Methods 2007; 39:175-191 DOI: https://doi.org/10.3758/BF03193146
Bjekic MD, Vlajinac HD, Sipetic SB, et al. Risk factors for Peyronie's disease: a case-control study. BJU Int. 2006; 97:570-574. DOI: https://doi.org/10.1111/j.1464-410X.2006.05969.x
Carrieri MP, Serraino D, Palmiotto F, et al. A case-control study on risk factors for Peyronie's disease. J Clin Epidemiol. 1998; 51:511-515. DOI: https://doi.org/10.1016/S0895-4356(98)00015-8
La Pera G, Pescatori ES, Calabrese M, et al. SIMONA Study Group. Peyronie's disease: prevalence and association with cigarette smoking. A multicenter population-based study in men aged 50-69 years. Eur Urol. 2001; 40:525-530. DOI: https://doi.org/10.1159/000049830
Tal R, Heck M, Teloken P, et al. Peyronie's disease following radi- cal prostatectomy: incidence and predictors. J Sex Med. 2010; 7:1254- 1261. DOI: https://doi.org/10.1111/j.1743-6109.2009.01655.x
El-Sakka AI. Prevalence of Peyronie's disease among patients with erectile dysfunction. Eur Urol. 2006; 49:564-569. DOI: https://doi.org/10.1016/j.eururo.2005.10.026
Ventimiglia E, Capogrosso P, Colicchia M, et al. Peyronie's disease and autoimmunity—a real-life clinical study and comprehensive review. J Sex Med. 2015; 12:1062-1069. DOI: https://doi.org/10.1111/jsm.12825
Ziegelmann MJ, Farrell MR, Levine LA. Clinical characteristics and surgical outcomes in men undergoing tunica albuginea plication for con- genital penile curvature who present with worsening penile deformity. World J Urol. 2020; 38:305-314. DOI: https://doi.org/10.1007/s00345-019-02787-7
Smith JF, Walsh TJ, Conti SL, et al. Risk factors for emotional and relationship problems in Peyronie’s disease. J Sex Med. 2008; 5:2179- 2184. DOI: https://doi.org/10.1111/j.1743-6109.2008.00949.x
Punjani N, Nascimento B, Salter C, et al. Predictors of Depression in Men With Peyronie's Disease Seeking Evaluation. J Sex Med. 2021; 18:783-788. DOI: https://doi.org/10.1016/j.jsxm.2021.02.002
Levine LA. The clinical and psychosocial impact of Peyronie's dis- ease. Am J Manag Care. 2013; 19(4 Suppl):S55-61.
Rosen R, Catania J, Lue T, et al. Impact of Peyronie's disease on sex- ual and psychosocial functioning: qualitative findings in patients and controls. J Sex Med. 2008; 5:1977-1984. DOI: https://doi.org/10.1111/j.1743-6109.2008.00883.x
Taylor FL, Levine LA. Peyronie's Disease. Urol Clin North Am. 2007; 34:517-534. DOI: https://doi.org/10.1016/j.ucl.2007.08.017
Bella AJ, Perelman MA, Brant WO, et al. Peyronie's disease (CME). J Sex Med. 2007; 4:1527-1538. DOI: https://doi.org/10.1111/j.1743-6109.2007.00614.x
Jordan GH, Carson CC, Lipshultz LI. Minimally invasive treatment of Peyronie's disease: evidence-based progress. BJU Int. 2014; 114:16- 24. DOI: https://doi.org/10.1111/bju.12634
Porst H, Burri A; European Society for Sexual Medicine (ESSM) Educational Committee. Current Strategies in the Management of Peyronie's Disease (PD)-Results of a Survey of 401 Sexual Medicine Experts Across Europe. J Sex Med. 2019; 16:901-908. DOI: https://doi.org/10.1016/j.jsxm.2019.03.404
El-Sakka AI. Medical, non-invasive, and minimally invasive treat- ment for Peyronie's disease: A systematic review. Andrology. 2021; 9:511-528. DOI: https://doi.org/10.1111/andr.12927
Copyright (c) 2023 the Author(s)
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
PAGEPress has chosen to apply the Creative Commons Attribution NonCommercial 4.0 International License (CC BY-NC 4.0) to all manuscripts to be published.
Downloads
Citations
